The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Oxy Bee Pollen Liquescence 3012
Oxy Bee Pollen Liquescence · BEE POLLEN 2 [hp_X]/118mL; ENGLISH SOLE 2 [hp_X]/118mL; DNA-DIRECTED RNA POLYMERASE SUBUNIT BETA (M. TUBERCULOSIS) 2 [hp_X]/118mL; BITTER ALMOND 3 [hp_X]/118mL; FUCUS VESICULOSUS 3 [hp_X]/118mL; LAMINARIA JAPONICA 3 [hp_X]/118mL; MEDICAGO SATIVA WHOLE 3 [hp_X]/118mL; ROYAL JELLY 3 [hp_X]/118mL; ZINC 4 [hp_X]/118mL; PANTOTHENIC ACID 6 [hp_X]/118mL; COMFREY ROOT 6 [hp_X]/118mL · Liquid · Oral · Professional Complementary Health Formulas
NDC 63083-3012-04 · 118 mL in 1 BOTTLE, DROPPER · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Oxy Bee Pollen Liquescence (Liquid)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Professional Complementary Health Formulas | BEE POLLEN 2 [hp_X]/118mL; ENGLISH SOLE 2 [hp_X]/118mL; DNA-DIRECTED RNA POLYMERASE SUBUNIT BETA (M. TUBERCULOSIS) 2 [hp_X]/118mL; BITTER ALMOND 3 [hp_X]/118mL; FUCUS VESICULOSUS 3 [hp_X]/118mL; LAMINARIA JAPONICA 3 [hp_X]/118mL; MEDICAGO SATIVA WHOLE 3 [hp_X]/118mL; ROYAL JELLY 3 [hp_X]/118mL; ZINC 4 [hp_X]/118mL; PANTOTHENIC ACID 6 [hp_X]/118mL; COMFREY ROOT 6 [hp_X]/118mL | Aug 26, 2026 | Sep 2, 2026 |
| Professional Complementary Health Formulas | BEE POLLEN 2 [hp_X]/118mL; ENGLISH SOLE 3 [hp_X]/118mL; DNA-DIRECTED RNA POLYMERASE SUBUNIT BETA (M. TUBERCULOSIS) 6 [hp_X]/118mL; BITTER ALMOND 2 [hp_X]/118mL; FUCUS VESICULOSUS 2 [hp_X]/118mL; LAMINARIA JAPONICA 3 [hp_X]/118mL; MEDICAGO SATIVA WHOLE 3 [hp_X]/118mL; ROYAL JELLY 3 [hp_X]/118mL; ZINC 6 [hp_X]/118mL; PANTOTHENIC ACID 3 [hp_X]/118mL; COMFREY ROOT 4 [hp_X]/118mL | Jul 22, 2026 | Aug 19, 2026 |
| Professional Complementary Health Formulas | BEE POLLEN 2 [hp_X]/118mL; BITTER ALMOND 3 [hp_X]/118mL; COMFREY ROOT 6 [hp_X]/118mL; DNA-DIRECTED RNA POLYMERASE SUBUNIT BETA (M. TUBERCULOSIS) 2 [hp_X]/118mL; ENGLISH SOLE 2 [hp_X]/118mL; FUCUS VESICULOSUS 3 [hp_X]/118mL; LAMINARIA JAPONICA 3 [hp_X]/118mL; MEDICAGO SATIVA WHOLE 3 [hp_X]/118mL; PANTOTHENIC ACID 6 [hp_X]/118mL; ROYAL JELLY 3 [hp_X]/118mL; ZINC 4 [hp_X]/118mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Oxy Bee Pollen Liquescence 3012 — NDC 63083-3012-04," retrieved September 3, 2026, https://drugdashboards.com/drug/63083301204.
Free to cite with attribution — see how the data is put together.